[Kangchen Pharmaceutical: Agkistrodon hemocoagulase for injection has obtained a new veterinary drug registration certificate] On September 15th, Kangchen Pharmaceutical (603590.SH) announced that the "Akidrus viper hemocoagulase for injection" jointly applied by the company and its wholly-owned subsidiary Beijing Aixinwan Pharmaceutical Technology Co., Ltd. was approved by the Ministry of Agriculture and Rural Affairs as a new veterinary drug for the hemostasis of surgical bleeding in dogs. As the first domestic hemocoagulase hemostatic drug to obtain a new veterinary drug registration certificate, this product has filled a gap in the pet hemostatic drug market. The company said it would not have a significant impact on performance in the short term.